|Bid||59.20 x 0|
|Ask||60.36 x 0|
|Day's Range||0.00 - 0.00|
|52 Week Range|
|Beta (5Y Monthly)||1.12|
|PE Ratio (TTM)||6.66|
|Forward Dividend & Yield||2.05 (2.79%)|
|Ex-Dividend Date||Jan 05, 2022|
|1y Target Est||N/A|
NEW YORK, May 13, 2022--JPMorgan Chase & Co. (NYSE: JPM) ("JPMorgan Chase" or the "Firm") has declared dividends on the outstanding shares of the Firm’s Series V preferred stock. Information can be found on the Firm’s Investor Relations website at https://www.jpmorganchase.com/ir/news.
JPMorgan Chase & Co. (JPM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Quantum Health, the industry-leading healthcare navigation and care coordination company, announced that it has once again been named one of the 50 Fastest-Growing Women-Owned/Led Companies by the Women Presidents Organization (WPO) and JPMorgan Chase. This marks Quantum Health's 11th year on the list.